Trial Profile
Clinical Trials Insight: 700017913
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2006
Price :
$35
*
At a glance
- Drugs Ranpirnase (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- Sponsors Tamir Biotechnology
- 07 Nov 2006 New trial record.